Deferred Tax Assets, Net of Valuation Allowance of Oncology Institute, Inc. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Oncology Institute, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • Oncology Institute, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2024 was $9,188,000, a 9.7% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Oncology Institute, Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $9,188,000 -$990,000 -9.7% 31 Dec 2024 10-K 26 Mar 2025 2024 FY
Q4 2023 $10,178,000 +$1,588,000 +18% 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q4 2022 $8,590,000 +$6,928,000 +417% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q4 2021 $1,662,000 -$459,000 -22% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q4 2020 $2,121,000 +$2,120,700 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 $70,000 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 $39,000 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $300* 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $300* 31 Dec 2019 10-Q 13 Nov 2020 2020 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.